Morgan Stanley Daxor Corp Call Options Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DXR
# of Institutions
9Shares Held
96.6KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA49KShares$455,4700.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny28.1KShares$261,2440.0% of portfolio
-
Keyes, Stange & Wooten Wealth Management, LLC Palm Coast, FL15.9KShares$147,8410.07% of portfolio
-
Sbi Securities Co., Ltd. Tokyo, M03.13KShares$29,0590.0% of portfolio
-
Ubs Group Ag326Shares$3,0280.0% of portfolio
About DAXOR CORP
- Ticker DXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 4,041,670
- Market Cap $37.5M
- Description
- Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used i...